At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
DTC Hearing Aidsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of Direct-to-consumer Hearing Aids on Conversation Efficiency and Listening Effort
In Brief
A clinical study evaluating DTC Hearing Aids for Hearing Loss and 2 related conditions. Completed, enrolled 30 participants across 2 sites.
Detailed Summary
The aim of this proposed project is to understand whether direct to consumer (DTC) hearing aids programmed to individual hearing losses, can reduce listening effort for effective communication. If DTC aids can provide benefits beyond amplification, then they could be an affordable option to reduce barriers to care and improve hearing aid uptake in adults with hearing loss.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
First PostedMay 2023
Primary CompletionDec 2023
Study CompletionDec 2023
TodayJul 2026
First PostedMay 11, 2023
Enrollment StartOct 25, 2022
Primary CompletionDec 1, 2023
Study CompletionDec 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.1 years ago
Interventions
DTC Hearing Aidsdevice
DTC hearing aid programmed to the individual participant.